NSC |
Compound |
Enrichment |
Correlation |
NSC 705331 |
2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- |
0.0414190425892871 |
0.14692564 |
NSC 708559 |
Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) |
0.0414190425892871 |
0.21703003 |
NSC 710895 |
3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide |
0.0414190425892871 |
0.22004441 |
NSC 720386 |
Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane |
0.0414190425892871 |
0.40969235 |
NSC 721049 |
7Z-Plakortide H |
0.0414190425892871 |
0.29324941 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0414190425892871 |
0.36269601 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0414190425892871 |
0.076685809 |
NSC 736041 |
7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne |
0.0414190425892871 |
0.34930091 |
NSC 740 |
Methotrexate |
0.0414190425892871 |
0.49989737 |
NSC 740476 |
Null |
0.0414190425892871 |
0.32626413 |